03920nam a22005295i 4500001001800000003000900018005001700027007001500044008004100059020001800100024003500118050001400153072001700167072002300184072001600207245012100223250001800344264006900362300006400431336002600495337002600521338003600547347002400583490005600607505095700663520110001620650001202720650001402732650003502746650004802781650001502829650002202844650002002866650001402886650002302900650001802923650001502941650002202956700014202978710003403120773002603154776003603180776003603216776003603252830005603288856004603344978-3-031-75445-6DE-He21320251030113235.0cr nn 008mamaa241019s2024    sz |    s    |||| 0|eng d  a97830317544567 a10.1007/978-3-031-75445-62doi 4aRC261-271 7aMJCL2bicssc 7aMED0620002bisacsh 7aMJCL2thema10aHematological Cancer Pathophysiology: An Interdisciplinary Approachh[electronic resource] /cedited by Nima Rezaei.  a1st ed. 2024. 1aCham :bSpringer Nature Switzerland :bImprint: Springer,c2024.  aXI, 302 p. 28 illus., 26 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda1 aInterdisciplinary Cancer Research,x2731-457X ;v100 aInterdisciplinary Approach in Hematological Cancers -- Immunodeficiency, Leukemia, and Lymphoma -- Pathogenesis and Consequences of a Disruption to the Intestinal Barrier Functions in Patients with Hematologic Malignancies -- Autophagy as a Limiting Factor to the Effectiveness of Tyrosine Kinase Inhibitors in Blood Cancers -- Immunogenetic Factors in the Pathogenesis of Myeloproliferative Neoplasms -- Germline Predisposition in the Field of Myeloproliferative Neoplasms -- Enteropathy-Associated T-cell Lymphoma: Epidemiology, Natural History and Management in the Current Era -- Molecular Pathogenesis of Hodgkin's Lymphoma: Advances Through the Key Player LMP1 and 3D Nanotechnology -- Updates on Molecular Pathogenesis of Non-Hodgkin's Lymphoma -- Intraocular Lymphoma -- Bleeding in the Setting of Lymphoma, with a Focus on Waldenström Macroglobulinaemia -- The Role of EBV and Immune Deregulation in the Development of IgG4-related Diseases.  aHematological cancers or blood cancers are a heterogeneous group of malignant neoplasms, including leukemia, lymphoma, and myeloma, primarily affect the blood and bone marrow. The “Hematological Cancer Pathophysiology: An Interdisciplinary Approach” is the tenth volume of the “Interdisciplinary Cancer Research” series, publishes a comprehensive volume on the pathophysiology of hematological cancers. This volume has an interdisciplinary approach in hematological cancers, including myeloproliferative neoplasms, T-cell lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, and intraocular lymphoma. Waldenstrom macroglobulinemia and IgG4-related diseases are also discussed in the last chapters. This interdisciplinary series is of special value to researchers working on hematology and oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to hematologists and oncologists who wish to extend their knowledge on hematological cancers. 0aCancer. 0aOncology. 0aTumorsxImmunological aspects. 0aDiseasesxCauses and theories of causation. 0aPathology. 0aHuman physiology.14aCancer Biology.24aOncology.24aTumour Immunology.24aPathogenesis.24aPathology.24aHuman Physiology.1 aRezaei, Nima.eeditor.0(orcid)0000-0002-3836-18271https://orcid.org/0000-0002-3836-18274edt4http://id.loc.gov/vocabulary/relators/edt2 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303175444908iPrinted edition:z978303175446308iPrinted edition:z9783031754470 0aInterdisciplinary Cancer Research,x2731-457X ;v1040uhttps://doi.org/10.1007/978-3-031-75445-6